| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| None | ||||||
| Postponed | ||||||
| YogaWorks (YOGA) | Cowen/ Stephens/ Guggenheim Securities | 5.00 | $12.00 | $14.00 | $65.00 | 1-Star |
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Calyxt (CLXT) | Citigroup/ Credit Suisse/ Jefferies | 6.06 | $8.00 | $10.00 | $54.55 | S/O |
| Clementia Pharmaceuticals (CMTA) | Morgan Stanley/ Leerink Partners | 7.15 | $13.00 | $15.00 | $100.10 | S/O |
| RBB Bancorp (RBB) | Sandler O’Neill/ Keefe, Bruyette & Woods (A Stifel Company)/ Stephens | 3.00 | $22.00 | $24.00 | $69.00 | S/O |
| Redfin (RDFN) | Goldman Sachs/ Allen & Company/ BofA Merrill Lynch/ RBC Capital Markets | 9.23 | $12.00 | $14.00 | $120.00 | S/O |
| Sienna Biopharmaceuticals (SNNA) | J.P. Morgan/ Cowen/ BMO Capital Markets | 4.33 | $14.00 | $16.00 | $65.00 | S/O |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of July 17, 2017 | Manager(s) | Offered | Raised | Price | 7/21/17 | Change |
| PetIQ (PETQ) | Jefferies/ William Blair | 6.25 | $100.00 | $16.00 | $23.32 | 45.75% |
| Calyxt (CLXT) | Citigroup/ Credit Suisse/ Jefferies | 7.00 | $56.00 | $8.00 | $10.81 | 35.13% |
| Kala Pharmaceuticals (KALA) | J.P. Morgan/ BofA Merrill Lynch | 6.00 | $90.00 | $15.00 | $19.10 | 27.33% |
| Federal Street Acquisition (FSACU) (u) | Citigroup/ BofA Merrill Lynch | 40.00 | $400.00 | $10.00 | $10.15 | 1.50% |
| Osprey Energy Acquisition (OSPRU) (u) | Credit Suisse | 25.00 | $250.00 | $10.00 | $10.02 | 0.20% |
| TPG RE Finance Trust (TRTX) | BofA Merrill Lynch/ Citigroup/ Goldman, Sachs/ Wells Fargo Securities/ Deutsche Bank Securities/ Morgan Stanley/ Barclays | 11.00 | $220.00 | $20.00 | $19.67 | -1.65% |